Cardiovascular and Thrombotic Complications after Covid-19 Vaccination

Aidonidis T. Georgios *

Interbalkan Medical Center, Thessaloniki, Greece.

*Author to whom correspondence should be addressed.


Abstract

The “Type of Article” of this paper is “Letter to the Editor”. This paper discuses about: “Cardiovascular and Thrombotic Complications after Covid-19 Vaccination

”. No formal abstract is available. Readers are requested to read the full article.

Keywords: Complication, cardiovascular disease, Covid-19 vaccine, myocarditis, pulmonary embolism


How to Cite

Georgios, A. T. (2022). Cardiovascular and Thrombotic Complications after Covid-19 Vaccination. Cardiology and Angiology: An International Journal, 11(4), 437–439. https://doi.org/10.9734/ca/2022/v11i4298


References

J. Ioannidis Infection fatality rate of COVID-19 inferred from seroprevalence data. Bulletin W.H.O. 2021;99:19-33F.

PMID: 3371633

PMCID: PMC7947934

DOI: 10.2471/BLT.20.265892

Dessie ZG, et al. Mortality-related risk factors of COVID-19: A systemic review and metanalysis of 42 studies and 429117 patients. BMC Inf. Diseases. 2021;21: 855.

Suzuki Y et al. SARS- CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vascular Pharmacology. 2021;137: 106823.

Lopez Castro J. Post-COVID-19 Syndrome (PC19S): Chronic Reactive Endotheliitis and Disseminated Vascular Disease. Acta Med Port. 2020;33(12):859.

DOI: 10.20344/amp.14612.

Sieiro-Santos C, López-Castro J. Post-coronavirus disease syndrome and disseminated microthrombosis: The role of the von Willebrand factor and antiphospholipid antibodies. Clinics (Sao Paulo). 2021;76:e2784.

DOI: 10.6061/clinics/2021/e2784.

Thomas S et al. Safety and efficacy of the BNT162b2 m-RNA Covid-19 Vaccine through 6 months. NEJM. 2021;385:1761-73.

Kounis N, et al. Kounis syndrome: A new twist on an old disease. Future Medicine. 2011;7(6).

Available:https://doi.org/10.2217/fca.11.63.

Kounis N, et al. Kounis Syndrome- not a single- organ arterial disorder but a multisystem and multidisciplinary disease. B. M. J. 2019;34:212-21.

Kounis N, et al. Allergic reactions to current available Covid-19 vaccines: Pathophysiology, Causality and therapeutic Considerations: Vaccines. 2021;9:221.

Rzymski P, et al. Thrombotic thrombocytopenia after COVID-19 vaccination: In search of the underlying mechanism. Vaccines.2021;9:559.

Palaiodimou L, et al. Cerebral venous sinus thrombosis and thrombotic events after vector- based COVID-19 vaccines. A systemic review and meta-analysis. Neurology. 2021;97(21).

Lei Y, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2. Research Leter. Circulation Research. 2021;128:1323-1326.

Gundry S. Observational findings of PULS cardiac findings for inflammatory markers in patients receiving mRNA vaccines. Circulation. 2021;144:Abstract 10721.

Witberg G. Myocarditis after COVID-19 vaccination in a large health care organization. NEJM. 2021;385:2132-2139.

Chua G, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination. Clinical infectious disease 2022;10(10):1-9.

Montgomery J, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US army, JAMA Cardiol;2021.